Menu
+
+
+
+
+
+
FDA formally recognized for the first time a public genetic database as a valid source of information to support clinical validity in premarket submissions for genetic tests, which could save developers the resources required to collect...
BioCentury employs a fully integrated multimedia platform — including publications, online data solutions and conferences — to provide its audience with authoritative and up-to-date intelligence about corporate strategy, partnering, emerging technology, clinical data, public policy and the financial markets.
